PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4,529 Cr | ₹3,393 Cr | ₹2,645 Cr | ₹3,812 Cr | ₹2,903 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹4,529 Cr |
| Mar2025 | ₹3,393 Cr |
| Mar2024 | ₹2,645 Cr |
| Mar2023 | ₹3,812 Cr |
| Mar2022 | ₹2,903 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,529 Cr | 33.50 | |
| Mar2025 | ₹3,393 Cr | 28.29 | |
| Mar2024 | ₹2,645 Cr | -30.62 | |
| Mar2023 | ₹3,812 Cr | 31.33 | |
| Mar2022 | ₹2,903 Cr | - | |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹26,106.8 Cr | 2.1% | 16.6% | -3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 2.1% |
16.6% |
-3.1% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses